Rituximab in refractory nephrotic syndrome

@article{Prytua2009RituximabIR,
  title={Rituximab in refractory nephrotic syndrome},
  author={Agnieszka Prytuła and Kazumoto Iijima and Koichi Kamei and Denis Geary and Errol Gottlich and Abdul Majeed and Mark Taylor and Stephen D Marks and Shamir Tuchman and Roberta R. Camilla and M. Milosav Ognjanovic and Guido Filler and Graham H R Smith and Kjell Tullus},
  journal={Pediatric Nephrology},
  year={2009},
  volume={25},
  pages={461-468}
}
The aim of this study was to establish the efficacy and safety of rituximab in refractory nephrotic syndrome (NS). Members of the International Paediatric Nephrology Association were asked to retrospectively fill in a questionnaire with details on the use of rituximab in their centres. We divided the data into three groups: group 1, patients with steroid-dependent and frequently relapsing NS; group 2, with steroid-resistant NS; group 3, with post-transplant recurrence of NS. Seventy… CONTINUE READING